SynthesisEuropean journal of preventive cardiology2025
Association of environmental metallic and metalloid contaminants with cardiovascular and all-cause mortality: an umbrella review of systematic reviews and meta-analyses.
Synthesis in European journal of preventive cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tackling metals to advance cardiovascular health.European journal of preventive cardiology · 2025Article
Corrections and comments
- Commented on by
Authors and funding
11 authors.
Funding
Abstract
aimsThe aim was to examine the relationship between exposure to environmental metallic and metalloid pollutants and cardiovascular disease (CVD) and all-cause mortality by integrating the information currently available from systematic reviews and meta-analyses. METHODS AND
resultsPubMed, Embase, and Web of Science for systematic reviews and meta-analyses were thoroughly searched up to 9 October 2024. Systematic reviews and meta-analyses of various kinds that evaluated the relationship between exposure to ambient metallic and metalloid pollutants and CVD and all-cause mortality were included. The methodological quality and the evidence quality were assessed using AMSTAR2 and GRADE, respectively. We identified 25 meta-analyses and 81 health outcomes-76 unique outcomes from observational studies and 5 unique outcomes from RCTs-from 8841 independent publications. Exposure to non-essential metallic and metalloid pollutants, including arsenic, lead, and cadmium as well as essential metallic and metalloid contaminants like copper, has been associated with an elevated risk of CVD events and CVD mortality, according to moderate-quality evidence. According to low-quality evidence, exposure to arsenic, lead, and cadmium increases the risk of CHD, while exposure to lead, cadmium, and copper is strongly associated with an increased risk of stroke and all-cause mortality. Further, zinc and selenium may be protective factors for CVD and all-cause mortality.
conclusionDespite variations in evidence gradients, environmental metallic and metalloid contaminants like arsenic, lead, cadmium, mercury, and copper are linked to CVD events and mortality, whereas zinc and selenium may offer protection. LAY SUMMARY: Non-essential environmental metallic and metalloid contaminant exposure is associated with a higher risk of CVDs and all-cause mortality, whereas essential metallic and metalloid may confer a protective benefit.Non-essential metallic and metalloid contaminants, such as arsenic, lead, and cadmium, raise the possibility of CVD events, CHD, and all-cause mortality, with lead and cadmium associated with higher risk of stroke.Essential metallic and metalloid contaminants like zinc and selenium can protect against CVD events and CHD, but too much selenium or copper may be harmful.
Indexed as
Identifiers
40037379What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.